Projects per year
Abstract
In this issue of Molecular Cell, Chen et al. (2017) demonstrate that the tumor suppressor protein ARF sensitizes cancer cells to programmed death through a surprising mechanism: ARF physically interacts with and antagonizes activation by acetylation of the master redox regulator NRF2, providing an unusual mode of posttranslational NRF2 regulation.
Original language | English |
---|---|
Pages (from-to) | 5-7 |
Number of pages | 3 |
Journal | Molecular Cell |
Volume | 68 |
Issue number | 1 |
DOIs | |
Publication status | Published - 5 Oct 2017 |
Fingerprint
Dive into the research topics of 'Epigenetic Control of NRF2-Directed Cellular Antioxidant Status in Dictating Life-Death Decisions'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Contribution by NRF2 Upregulation to Lung Carcinogenesis and the Possible Therapeutic Value of NRF2 Inhibition by GSK-3 (Joint with Universities of St Andrews, Edinburgh and Pennsylvania)
Dinkova-Kostova, A. (Investigator), Hayes, J. (Investigator), Henderson, C. (Investigator), Keyse, S. (Investigator), Lamond, A. (Investigator) & Sutherland, C. (Investigator)
1/05/16 → 31/10/19
Project: Research
-
The Spatiotemporal Regulation of the Keap1/Nrf2 Pathway (Joint with University College London)
Dinkova-Kostova, A. (Investigator)
Biotechnology and Biological Sciences Research Council
30/09/14 → 27/02/18
Project: Research